Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a strategic...
North America’s Authentic Icelandic Skyr Celebrates Autumn: Icelandic Provisions Launches Pumpkin Spice
EIN Presswire
The Season's Most Beloved Flavor Meets a Thousand Years of Icelandic Tradition, Here for a Limited Time NEW YORK, NY, UNITED STATES, August 19, 2026 /EINPresswire.com/ -- Before fall's first leaf turns and the chill is in the air, Icelandic...
Exercise Northern Viking 2026 Marks 75 Years Of U.S.-Iceland Defense Cooperation
DVIDS - Georgia
U.S. Sailors, Marines, Airmen, and Soldiers have arrived in Keflavik, Iceland, joining forces with the Icelandic Coast Guard and other NATO Allies to officially kick off U.S. Sixth Fleet’s Northern Viking 2026 (NV26) exercise during an opening...
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
GlobeNewswire, Inc.
- Positive CHMP opinion supports potential commercialization of obicetrapib monotherapy and obicetrapib/ezetimibe fixed-dose combination in Europe - - Recommendation based on positive Phase 3 BROADWAY, BROOKLYN, and TANDEM data - - European...
Icelandirect Earns SSCI Certification, Strengthening Its Ability to Serve Brands Selling Across Major Retail Channels
GlobeNewswire, Inc.
CLIFTON, N.J., July 09, 2026 (GLOBE NEWSWIRE) -- Icelandirect, LLC, a leading U.S.-based contract manufacturer of supplements, vitamins, and nutraceuticals for human and pet brands, has achieved Supplement Safety & Compliance Initiative (SSCI)...
SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma
GlobeNewswire, Inc.
BRUSSELS, July 01, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company designed to address rare and urgent conditions, today announced that it has completed the acquisition of exclusive development and...
Icelandirect Achieves FSSC 22000 Certification, Reinforcing Its Commitment to the Highest Standards in Supplement Manufacturing
GlobeNewswire, Inc.
CLIFTON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Icelandirect, LLC, a leading U.S.-based contract manufacturer of supplements, vitamins, and nutraceuticals for both human and pet brands, is pleased to announce the successful completion of its FSSC...
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026
GlobeNewswire, Inc.
ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in...
Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease
GlobeNewswire, Inc.
PREDICT-1 is the first genotype-based registrational trial in dry eye disease (DED), with the potential of delivering a first-in-class precision medicine treatment in DED This FDA-aligned trial targets the specific TNFR1 genotype to maximize...
Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference
GlobeNewswire, Inc.
ZUG, Switzerland, June 08, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with...
Naval Medical Forces Atlantic Honors Capt. Chad McKenzie Upon Retirement After 30 Years of Distinguished Naval Service
DVIDS - Georgia
PORTSMOUTH, Va. — Capt. Chad McKenzie, Medical Service Corps, U.S. Navy, was honored for 30 years of service during a retirement ceremony held May 29, 2026, in the auditorium of Naval Medical Center Portsmouth.
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million
GlobeNewswire, Inc.
BRUSSELS, May 19, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) today announced that they have entered into an agreement under which SERB will acquire the exclusive development and...
Icelandic firm sets up ‘tapering clinic’ in Maine
Maine International Trade Center
A clinic headquartered in Reykjavík, Iceland, has launched a location at 225 Gorham Road in South Portland.
Alvotech to Report Financial Results for H1 2026
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced...
New Memoranda pave the way for €50 million in investments in local development and public health
Government of Slovenia
SLOVENIA, May 18 - The Memoranda were signed by His Excellency Vegard Kaale, Ambassador of the Kingdom of Norway, Her Excellency Helga Hauksdóttir, Ambassador of Iceland, representing the Donor States, i.e., the Kingdom of Norway, the Principality...
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
GlobeNewswire, Inc.
Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may bring to patients.
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
GlobeNewswire, Inc.
- Company remains on track for BLA resubmissions in the second quarter REYKJAVIK, Iceland, May 11, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of...
Gaza: Red Cross Field Hospital in Rafah undergoes overhaul to continue addressing urgent health care needs
International Committee of the Red Cross
“The entry of medical equipment and supplies for the Red Cross Field Hospital is a positive step towards responding to the medical needs of people in Gaza,” said Julien Lerisson, the ICRC’s head of delegation in Israel and the Occupied...
Two years on: upgrading the Red Cross Field Hospital in Rafah
International Committee of the Red Cross
Over the last two years, the Red Cross Field Hospital has been a constant in Gaza's fractured health landscape.
Sign up for:
Iceland Health Focus
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.